- DVM – Graduated CUM LAUDE, University of Torino, Italy - 1996
- Research Scholar Associate Post Doctorate, North Carolina State University - 1999- 2000
- Research Associate Post Doctorate – Intern in Oncology, North Carolina State University - 2002
- Educational Commission for Foreign Veterinary Graduates Certification, North Carolina State University - 2003
- Residency in Comparative Oncology, Purdue University - 2006
- Master Degree in Veterinary Clinical Sciences, Purdue University - 2006
- Diplomate of the American College of Veterinary Internal Medicine (Oncology) since 2006
- Diplomate of the European College of Veterinary Internal Medicine (Oncology) since 2007
- Clinical Trial Research Assistant, North Carolina State University, 2000
- Clinical Instructor in Oncology, North Carolina State University, 2002 -2003
- Medical Oncologist, Carolina Veterinary Specialists, 2006-2007
- Medical Oncologist, Veterinary Specialty Hospital of the Carolinas, 2007-2008
- Assistant Clinical Professor of Oncology, University of Minnesota, 2008-present
- Phi Zeta Honor Society of Veterinary Medicine
- Veterinary Cancer Society
- European College of Veterinary Internal Medicine
- American College of Veterinary Internal Medicine
- Masonic Cancer Center
Dr. Borgatti is primarily interested in clinical research applications of novel therapeutics and targeted treatments of cancer.
Dr. Borgatti teaches in the Comparative Oncology course where her didactic instructional areas include bone tumors, soft tissue sarcomas, and paraneoplastic syndromes. She is also one of the instructors for the Clinical Skills course. She enjoys clinical teaching with students, interns and residents involved in the Clinical Oncology rotations within the Veterinary Teaching Hospital, Oncology service.
Small animal clinical oncology, comparative oncology, targeted therapeutics.
- Borgatti Jeffreys A, Knapp DW, Carlton WW, Thomas RM, Bonney PL, deGortari A, Lucroy MD. Influence of Asparaginase on a Combination Chemotherapy Protocol for Canine Multicentric Lymphoma. J Am Anim Hosp Assoc. Jul-Aug; 41 (4): 221-6, 2005.
- David J. Waters, Antonella Borgatti Jeffreys. Critical Issues in Aging and Cancer: Implications for Effective Cancer Prevention. Federation of Animal Science Societies FASS Symposium, Joint Annual Meeting American Society of Animal Science, Cincinnati, OH (July 28, 2005) and North American Veterinary Conference, Orlando, FL (January 10, 2006).
- A Borgatti-Jeffreys, SB Hooser, MA Miller, RM Thomas, A deGortari, MD Lucroy. A Candidate Second-Generation Photosensitizer for Photodynamic Therapy in Veterinary Medicine. Am J of Vet Res. Apr; 68 (4): 399-404, 2007.
- Greenberg CB, Boria P, Borgatti-Jeffreys A, Raskin RE, and Lucroy MD. Phase II Clinical Trial of Combination Chemotherapy with Dexamethasone for Lymphoma in Dogs. J Am Anim Hosp Assoc. 4: 27-32, 2007.
- Dhawan D, Borgatti-Jeffreys A, Zheng R, Stewart JC, Knapp DW. Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells. Mol Cancer Therapeutics. Apr 7(4): 897-904, 2008.
- Antonella Borgatti e Paolo Buracco. Un legame che va oltre l’amicizia: cane, uomo e oncologia comparata. Veterinaria. 23 (2), 2009.
- Antonella Borgatti. “Plasma Cell Tumors”. Chapter 70, 511-519. In: Weiss D.J. &
- Wardrop K.J. Schalm’s Veterinary Hematology, 6th edition. Wiley-Blackwell, 2010.
- Waters DJ, Borgatti Jeffreys A. Endocrine System. Chapter 6. In: Hudson LC, Hamilton WP, ed. Atlas of Feline Anatomy for Veterinarians, 2nd edition. Teton NewMedia, 2010.
- Ito D, Endicott MM, Jubala CM, Helm KM, Burnett RC, Husbands BD, Borgatti A, Henson MS, Burgess KE, Bell JS, Kisseberth WC, Valli VE, Cutter GR, Avery AC, Hahn KA, O’Brien TD, Modiano JF. (2011). A lymphoid progenitor population in canine non-Hodgkin lymphoma. J Vet Intern Med. Jul:25(4):890-896, 2011.
Awards and Honors
- One-year scholarship from the University of Torino to gain specialized training in small animal oncology at North Carolina State University, College of Veterinary Medicine, 1999
- Omicron Chapter of Phi Zeta Honor Society of Veterinary Medicine, elected to membership.
- Impact of Palladia/Piroxicam/Cyclophosphamide Maintenance Therapy on the Survival Time of Dogs with Appendicular Osteosarcoma Following Amputation and Carboplatin Chemotherapy (Role: Principal Investigator)
- LICKing Lymphoma: Ablation of tumor initiating cells by P-glycoprotein inhibition: Proof of principle study in canine diffuse large B-cell lymphoma (Role: Co-investigator)
- Novel Therapeutic Agent for the Treatment of Solid Tumors in Dogs - NTST study for dogs with measurable melanoma, osteosarcoma, soft tissue sarcoma, squamous cell carcinoma (Role: Co-investigator)
For a complete list of clinical trials available at the University of Minnesota, please visit the Clinical Investigation Center (CIC) page at http://www.cvm.umn.edu/cic/